Post-Vaccine Distribution, Mergers Will Dominate Biotech Industry ETFs
November 24, 2020 at 12:21 PM EST
The COVID-19 pandemic put biotech in the spotlight as companies around the globe worked feverishly to create a vaccine. Once a tried-and-true vaccine is developed and subsequently incorporated as standard fare in medical practice, one driver of biotech will be mergers and acquisitions, which should...